Device / Technology News

RSS

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.

25 Oct 2010

New disease map resource can reduce MRSA infection in hospitalized patients

Gary A. Puckrein, Ph.D., CEO of the National Minority Quality Forum, and Gary Doern, Ph.D., nationally recognized infectious disease expert, will host the launch of the national MRSA Atlas by way of a webinar.

25 Oct 2010

Cellectis and CiRA commence iPS cell scientific collaboration

Cellectis, the French genome engineering specialist, and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced today that they have started a scientific collaboration to combine Cellectis' genome engineering technologies with CiRA's induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools.

25 Oct 2010

Kryptonite adhesive can improve quality of heart patients recovering from open-chest surgery

New research shows that a surgical procedure using a cutting-edge super glue pioneered a year ago by Calgary researchers can improve the recovery of heart patients recovering from open-chest surgery, Dr. Paul Fedak today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Kanto Chemical to distribute NanoIntegris' carbon nanotubes in Japan

NanoIntegris, Inc. announced today that it entered into a distribution contract with Kanto Chemical Co., Inc. NanoIntegris is the world's only supplier of 99% enriched metallic and semiconducting single-walled carbon nanotubes. Research companies and universities are currently using NanoIntegris' carbon nanotubes to develop emerging technologies such as printable transistors, chemical sensors, and biomedical applications such as imaging and drug delivery.

25 Oct 2010

Maven Semantic updates Antiviral research database

Maven Semantic announces updates to their Antiviral research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

25 Oct 2010

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.

25 Oct 2010

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.

25 Oct 2010

Scientists use Affymetrix custom microarray to advance malarial study

Affymetrix, Inc. announced today that an international team of researchers led by scientists at Boston College, the Broad Institute, and Imperial College London used an Affymetrix custom microarray to advance the study of malaria by assessing the variation in genetic structure and detecting known and novel genetic differences among malaria vector mosquito populations.

25 Oct 2010

New ear implant for Meniere’s disease

Meniere’s disease is a disease that affects the inner ear – a region responsible for balance. It affects 1% of Americans and can be quite disabling since it leads to attacks of vertigo. At present medications can not completely cure the condition and surgery is often unsuccessful.

24 Oct 2010

Wright Medical launches PRO-STIM Injectable Inductive Graft

Wright Medical Group, Inc. a global orthopaedic medical device company, is pleased to announce the full commercial launch of PRO-STIM Injectable Inductive Graft.

22 Oct 2010

NCRR awards 450 Recovery Act instrumentation grants to NIH-funded scientists

Leading-edge, shared technologies are an important component of advancing research to improve health. Specialized instruments such as high-powered electron microscopes, high-resolution mass spectrometers and supercomputers that rapidly process vast amounts of data can enable breakthrough discoveries in preventions, treatments and cures for diseases.

22 Oct 2010

Primary care-based patient navigation can reduce healthcare disparities

A new research study conducted by Boston University School of Medicine (BUSM) shows that patient navigation services significantly improve biennial mammography screening rates among inner city women. The results, published online in the Journal of General Internal Medicine, indicate the importance of patient navigation in reducing health disparities in vulnerable patient populations.

22 Oct 2010

New assessment tool to measure cognitive representation of chronic disease

What do we mean by "common sense" when we talk about a disease? What affects the ideas and beliefs that patients have of their disease. Researchers at the University of Granada have developed a test for measuring and assessing chronic patients' cognitive representation of their disease. This advance will enable the development of clinical psychological treatments much more efficient than those currently employed.

22 Oct 2010

Study evaluates protective effect of airbags on kidneys, upper urinary tract

Occupants in motor vehicles with airbags are much less likely to suffer kidney or renal damage in a crash than are occupants in vehicles without airbags, according to a new study in the September Journal of the American College of Surgeons.

22 Oct 2010

EES implantation reduces restenosis, repeat revascularization in patients with calcified culprit lesions

Two new studies have determined that everolimus-eluting stent (EES) implantation reduced the incidence of restenosis and repeat revascularization in patients with calcified culprit lesions, and had fewer clinical events. Results show the rate of major cardiac adverse events in EES-treated patients with calcified lesions were higher than in those for noncalcified lesions, but remained lower than the results of previously reported stent studies.

22 Oct 2010

New technology could prove effective in mentoring general surgeons in remote locations

Telementoring may be an effective way for subspecialist surgeons to assist remotely located general surgeons in the care of patients in need of emergency subspecialty surgical procedures, according to new research findings published in the September issue of the Journal of the American College of Surgeons.

22 Oct 2010

Researchers find new minimally invasive option to determine natural causes of death

Researchers found that the combination of computed tomography (CT), postmortem CT angiography (CTA) and biopsy can serve as a minimally invasive option for determining natural causes of death such as cardiac arrest, according to a study in the November issue of the American Journal of Roentgenology.

22 Oct 2010

Laser pulses enable skin rejuvenation

Laser pulses enable skin rejuvenation, as research at Eindhoven University of Technology (TU/e) has shown. Laser treatment introduces heat into the skin. Under the influence of heat shocks of 45°C, skin cells produce more collagen. This is the protein that gives the skin its firmness and elasticity. Susanne Dams describes this process in the dissertation for which she gained her PhD degree from the Biomedical Engineering Department at TU/e.

22 Oct 2010

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.

22 Oct 2010

Device / Technology News

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

New disease map resource can reduce MRSA infection in hospitalized patients

Cellectis and CiRA commence iPS cell scientific collaboration

Kryptonite adhesive can improve quality of heart patients recovering from open-chest surgery

Kanto Chemical to distribute NanoIntegris' carbon nanotubes in Japan

Maven Semantic updates Antiviral research database

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Shrink announces agreement to produce high content screening tool for biotech R&D subsidiary

Scientists use Affymetrix custom microarray to advance malarial study

New ear implant for Meniere’s disease

Wright Medical launches PRO-STIM Injectable Inductive Graft

NCRR awards 450 Recovery Act instrumentation grants to NIH-funded scientists

Primary care-based patient navigation can reduce healthcare disparities

New assessment tool to measure cognitive representation of chronic disease

Study evaluates protective effect of airbags on kidneys, upper urinary tract

EES implantation reduces restenosis, repeat revascularization in patients with calcified culprit lesions

New technology could prove effective in mentoring general surgeons in remote locations

Researchers find new minimally invasive option to determine natural causes of death

Laser pulses enable skin rejuvenation

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News